GENEVA, Feb. 15 -- SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD (Zone A, 4F, 289 Digitland, 2 Hongliu Road, Futian DistrictShenzhen, Guangdong 518017), 深圳信立泰药业股份有限公司 (中国广东省深圳市福田区福保街道福保社区红柳道2号289数字半岛4层A区) filed a patent application (PCT/CN2024/111004) for "RXFP1 RECEPTOR MODULATOR AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF" on Aug 09, 2024. With publication no. WO/2025/031481, the details related to the patent application was published...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.